Skip to main content

Advertisement

SpringerLink
Log in

Review of the 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: What is New and Why?

  • Women + Heart Disease (E Jackson, Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

In September 2014, the 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes (NSTE-ACS) was released electronically; it was published in print 3 months later, in December 2014. The management of NSTE-ACS has evolved significantly in recent years, and a number of novel agents are now available for use (e.g., prasugrel, ticagrelor). In addition, several key diagnostic and therapeutic agents that were formerly considered hallmarks in the treatment of acute coronary syndrome have fallen out of favor (e.g., glycoprotein inhibitors, CK-MB). The 2014 AHA/ACC NSTE-ACS guideline document is the first comprehensive publication for the treatment of non-ST-elevation acute coronary syndromes since 2007; this review paper serves as an overview of the 2014 NSTE-ACS guideline, with emphasis on several paramount changes since the 2007 version.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Amsterdam EA. AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. Circulation. 2014;130:e344–426.

    Article  PubMed  Google Scholar 

  2. Go AS. Heart disease and stroke statistics—2014 update. Circulation. 2014;129(3):e28–e292.

    Article  PubMed  Google Scholar 

  3. Yeh RW. Population trends in the incidence and outcomes of acute myocardial infarction. NEJM. 2010;362(23):2155–65.

    Article  CAS  PubMed  Google Scholar 

  4. Antman E. The TIMI risk score for unstable angina/non–ST elevation MI. JAMA. 2000;284(7):835–42.

    Article  CAS  PubMed  Google Scholar 

  5. Thygesen K. Third universal definition of myocardial infarction. JACC. 2012;60(16):1581–98.

    Article  PubMed  Google Scholar 

  6. Anderson J. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. JACC. 2007;50(7):e1–e157.

    Article  PubMed  Google Scholar 

  7. Newby LK. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. JACC. 2006;47(2):312–8.

    Article  CAS  PubMed  Google Scholar 

  8. Volz K. Creatine kinase-MB does not add additional benefit to a negative troponin in the evaluation of chest pain. Am J Emerg Med. 2012;30(1):188–90.

    Article  PubMed  Google Scholar 

  9. Volz K. Should creatine kinase-MB index be eliminated in patients with indeterminate troponins in the ED. Am J Emerg Med. 2012;30(8):1574–6.

    Article  PubMed  Google Scholar 

  10. Meine T. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J. 2005;149(6):1043–9.

    Article  CAS  PubMed  Google Scholar 

  11. Becker R. Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J. 2011;32(23):2933–44.

    Article  CAS  PubMed  Google Scholar 

  12. Wallentin L. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. NEJM. 2009;361(11):1045–57.

    Article  CAS  PubMed  Google Scholar 

  13. Montalescot G. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. NEJM. 2013;369(11):999–1010.

    Article  CAS  PubMed  Google Scholar 

  14. Wiviott S. Prasugrel versus clopidogrel in patients with acute coronary syndromes. NEJM. 2007;357(20):2001–15.

    Article  CAS  PubMed  Google Scholar 

  15. Stone G. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. JAMA. 2007;297(6):591–602.

    Article  CAS  PubMed  Google Scholar 

  16. Giugliano R. Early versus delayed, provisional eptifibatide in acute coronary syndromes. NEJM. 2009;360(21):2176–90.

    Article  CAS  PubMed  Google Scholar 

  17. Smith S. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease – 2011 update. JACC. 2011;58(23):2432–46.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stanford University, 870 Quarry Road, Falk CVRC, Stanford, CA, 94305, USA

    Brian G. Howard

  2. Emory University School of Medicine, Emory Heart and Vascular Center, 49 Jesse Hill Jr Dr SE, Atlanta, GA, 30303, USA

    Nanette K. Wenger

Authors
  1. Brian G. Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nanette K. Wenger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Brian G. Howard or Nanette K. Wenger.

Ethics declarations

Conflict of Interest

Dr. Howard and Dr. Wenger have no relevant disclosures.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Additional information

This article is a part of Topical Collection on Women and Heart Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Howard, B.G., Wenger, N.K. Review of the 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: What is New and Why?. Curr Cardiovasc Risk Rep 10, 17 (2016). https://doi.org/10.1007/s12170-016-0496-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12170-016-0496-3

Keywords

Search

Navigation